Astrana Health is back in focus after analysts trimmed their fair value estimate from $40.25 to $35.67, a shift that slightly reduces the implied upside in current models. This reset lines up with ...

Objectives This study aimed to determine whether certain lifestyle factors, specifically alcohol consumption, smoking, physical activity, sleep duration and sleep quality, are associated with an ...

By Matt Tracy and Saeed Azhar Feb 23 (Reuters) - Software companies are delaying debt deals as higher borrowing costs and ...

Recent SaaS-driven selloff has pushed BDC sector valuations to deep discounts, with a median P/NAV of 0.77x. Click here to read what investors need to know.